Circulating microparticles in severe preeclampsia

Clinica Chimica Acta

Volumn 414, Issue , 2012, Pages 253-258

  Marques, Fabiana K ^a   Campos, Fernanda M F ^b   Filho, Olindo A M ^b   Carvalho, Andrea T ^b   Dusse, Luci M S ^a   Gomes, Karina B ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Coagulation; Inflammation; Microparticles; Preeclampsia

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIAL MICROPARTICLE; ERYTHROCYTE MICROPARTICLE; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE MICROPARTICLE; LYMPHOCYTE MICROPARTICLE; MAJOR CLINICAL STUDY; MEMBRANE MICROPARTICLE; MONOCYTE MICROPARTICLE; NEUTROPHIL MICROPARTICLE; PLATELET COUNT; PLATELET MICROPARTICLE; PREECLAMPSIA; PRIORITY JOURNAL; SYNCYTIOTROPHOBLAST MICROPARTICLE; BLOOD; COMPUTER PROGRAM; CYTOLOGY; ENDOTHELIUM CELL; ERYTHROCYTE; FLOW CYTOMETRY; PREGNANCY; SEVERITY OF ILLNESS INDEX; THROMBOCYTE COUNT;

ADULT; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; ENDOTHELIAL CELLS; ERYTHROCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; PLATELET COUNT; PRE-ECLAMPSIA; PREGNANCY; SEVERITY OF ILLNESS INDEX; SOFTWARE; YOUNG ADULT;

EID: 84867628025     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.09.023     Document Type: Article

References (41)

1. Wang, A., Rana, S., Karumanchi, S.A., Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology 24 (2009), 147–158.
2. Trogstad, L., Magnus, P., Stoltenberg, C., Pre-eclampsia: risk factors and causal models. Best Pract Res Clin Obstet Gynaecol 25 (2011), 329–333.
3. Turner, J.A., Diagnosis and management of pre-eclampsia: an update. Int J Womens Health 30 (2010), 327–337.
4. Young, B.C., Levine, R.J., Karumanchi, S.A., Pathogenesis of preeclampsia. Annu Rev Pathol Mech Dis 5 (2010), 173–192.
5. Roberts, J.M., Lain, K.Y., Recent insights into the pathogenesis of pre-eclampsia. Placenta 23 (2002), 359–372.
6. Poston, L., Endothelial dysfunction in pre-eclampsia. Pharmacol Rep 58 (2006), 69–74.
7. Walsh, S.W., Vaughan, J.E., Wang, Y., Roberts, L.J., Placental isoprostane is significantly increased in preeclampsia. FASEB J 14 (2000), 1289–1296.
8. Roveri-Querini, P., Castiglioni, M.T., Sabbadini, M.G., Manfredi, A.A., Signals of cell death and tissue turnover during physiological pregnancy, pre-eclampsia, and autoimmunity. Autoimmunity 40 (2007), 290–294.
9. Messerli, M., May, K., Hansson, S.R., et al. Feto-maternal interactions in pregnancies: placental microparticles activate peripheral blood monocytes. Placenta 31 (2010), 106–112.
10. Redman, C.W., Sargent, I.L., Circulating microparticles in normal pregnancy and pre-eclampsia. Placenta 29 (2008), 73–77.
11. Szarka, A., Rigó J., Lázár, L., Beko, G., Molvarec, A., Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol, 11, 2010, 59.
12. Molvarec, A., Szarka, A., Walentin, S., Szucs, E., Nagy, B., Rigó J., Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia. Hypertens Res 33 (2010), 892–898.
13. Molvarec, A., Szarka, A., Walentin, S., et al. Serum heat shock protein 70 levels inrelation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia. Clin Chim Acta 412 (2011), 1957–1962.
14. Meziani, F., Tesse, A., Andriantsitohaina, R., Microparticles are vectors of paradoxical information in vascular cells including the endothelium: role in health and diseases. Pharmacol Rep 60 (2008), 75–84.
15. Chironi, G.N., Boulanger, C.M., Simon, A., George, F.D., Freyssinet, J.M., Tegui, A., Endothelial microparticles in diseases. Cell Tissue Res 335 (2009), 143–151.
16. Mause, S.F., Weber, C., Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 107 (2010), 1047–1057.
17. Goswami, D., Tannetta, D.S., Magee, L., et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 27 (2006), 56–61.
18. Tesse, A., Meziani, F., David, E., Microparticles from preeclamptic women induce vascular hyporeactivity in vessels from pregnant mice through an overproduction of NO. Am J Physiol Heart Circ Physiol 293 (2007), 520–525.
19. Combes, V., Taylor, T., Juhan-Vague, I., et al. Circulating endothelial microparticles in Malawian children with severe falciparum malaria complicated with coma. JAMA 291 (2004), 2542–2544.
20. Faille, D., Combes, V., Mitchell, A., et al. Platelet microparticles: a new player in malaria parasite cytoadherence to human brain endothelium. FASEB J 23 (2009), 3449–3458.
21. Lock, C.A., Nieuwland, R., Sturk, A., Hau, C.M., Boer, K., Vanbavel, E., Microparticle-associated P-selectin reflects platelet activation in preeclampsia. Platelets 18 (2007), 68–72.
22. Orozco, A.F., Jorgez, C.J., Horne, C., et al. Membrane protected apoptotic trophoblast microparticles contain nucleic acids. Am J Pathol 173 (2008), 1595–1608.
23. Alijotas-Reig, J., Palacio-Garcia, C., Farran-Codina, I., Ruiz-Romance, M., Llurba, E., Vilardell-Tarres, M., Circulating cell-derived microparticles in severe preeclampsia and in fetal growth restriction. Am J Reprod Gynecol 67 (2011), 140–151.
24. Lok, C.A., Van Der Post, J.A., Sargent, I.L., Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia. Hypertens Pregnancy 27 (2008), 344–360.
25. Redman, C.W., Bonnar, J., Beilen, L., Early platelet consumption in preeclampsia. Br Med J 1 (1978), 467–469.
26. González-Quintero, V.H., Smarkusky, L.P., Jiménez, J.J., Elevated plasma endothelial microparticles: preeclampsia versus gestational hypertension. Am J Obstet Gynecol 191 (2004), 1418–1424.
27. Brodsky, S.V., Zhang, F., Nasjletti, A., Goligorsky, M.S., Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol 286 (2004), H1910–H1915.
28. Sarrel, P.M., Lindsay, D.C., Poole-Wilson, P.A., et al. Hypothesis: inhibition of endothelium-derivate relaxing factor by haemoglobin in the pathogenesis of pre-eclampsia. Lancet 336 (1990), 1030–1032.
29. Silva, R.F., Resende, L.S., Cardoso, B.R., Abbade, J.F., Peraçou, J.C., Significado da presença de esquizócitos no sangue periférico de gestantes com pré-eclâmpsia. Rev Bras Ginecol Obstet 30 (2008), 406–412.
30. VanWijk, M.J., Nieuwland, R., Boer, K., Van der Post, J.A., VanBavel, E., Sturk, A., Microparticle subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction. Am J Obstet Gynecol 187 (2002), 450–456.
31. Meziani, F., Tesse, A., David, E., et al. Shed membrane particles from preeclamptic women generate vascular wall inflammation and blunt vascular contractility. Am J Pathol 169 (2006), 1473–1483.
32. Mellembakken, J.R., Aukrust, P., Olafsen, M.K., Ueland, T., Hestdal, K., Videm, V., Activation of leukocytes during the uteroplacental passage in preeclampsia. Hypertension 39 (2002), 155–160.
33. Stallmach, T., Hebisch, G., Orban, P., Lu, X., Aberrant positioning of trophoblast and lymphocytes in the feto-maternal interface with pre-eclampsia. Virchows Arch 434 (1999), 207–211.
34. Mesri, M., Altieri, D.C., Endothelial cell activation by leukocyte microparticles. J Immunol 161 (1998), 4382–4387.
35. VanWijk, M.J., Kublickiene, K.R., Boer, K., VanBavel, E., Vascular function in preeclampsia. Cardiovasc Res 47 (2000), 38–48.
36. Redman, C.W., Sargent, I.L., Placental debris, oxidative stress and preeclampsia. Placenta 21 (2000), 597–602.
37. Redman, C.W., Sargent, I.L., The pathogenesis of pre-eclampsia. Gynecol Obstet Fertil 29 (2001), 518–522.
38. Germain, S.J., Sacks, G.P., Soorana, S.R., Sargent, I.L., Redman, C.W., Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 178 (2007), 5949–5956.
39. Davies, J.O., Davies, E.R., Howe, K., et al. Practical applications of a monoclonal antibody (NDOG2) against placental alkaline phosphatase in ovarian cancer. J R Soc Med 78 (1985), 899–905.
40. von Dadelszen, P., Hurst, G., Redman, C.W., Supernatants from co-cultured endothelial cells and syncytiotrophoblast microvillous membranes activate peripheral blood leukocytes in vitro. Hum Reprod 14 (1999), 919–924.
41. Southcombe, J., Tennetta, D., Redman, C., Sargent, I., The Immunomodulatory role of syncytiotrophoblast microvesicles. PLoS One, 6, 2011, e20245.